InvestorsHub Logo
Followers 9
Posts 1206
Boards Moderated 0
Alias Born 07/06/2011

Re: None

Monday, 03/09/2015 2:16:51 PM

Monday, March 09, 2015 2:16:51 PM

Post# of 45771
Cdex CEO past Failures

From the way back machine. Everyone needs a good laugh! Here is more crap shoveled in 2011 by CEO bumfield.....

TUCSON, AZ--(Marketwire - 01/07/11) - CDEX Inc. (OTC.BB:CEXI - News)

http://finance.yahoo.com/news/CDEX-Signs-Agreement-With-iw-4128201131.html
.""We met with the CDEX team at the ASHP Midyear Conference and were very impressed with the ValiMed Validation Systems," stated Marc Marchand, CEO of HealthContrax. "We believe the ValiMed has tremendous market potential as hospitals and other healthcare agencies focus on patient safety and drug loss prevention."About HealthContrax LLC

Tremendous potential! Hilarious!!!

."The distribution partnership with HealthContrax grants access to national Group Purchasing Organizations that contract with thousands of hospitals domestically, directly extending the sales reach for our ValiMed Validation Systems," stated Jeff Brumfield, CEO and Chairman of the Board of CDEX Inc

“We believe CDEX is well positioned to support increased demand for our ID2 product line and the full launch of the new ValiMed™ G4 Medication Validation System later this year. The G4 will be used as an end-of-line defense to increase patient protection while providing a safety net for the ever increasing problem of narcotics diversion in the clinical and hospital environments. We are very pleased with our progress year to date. Our recent developments coupled with the continued support of our shareholders should allow us to execute business plan and growth strategy for the foreseeable future,” Brumfield stated
http://www.ibtimes.com/cdex-inc-cexi-reports-q2-business-and-financial-results-467978

Full Launch, suckers! Four years later, same crap!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.